Expanding at a healthy CAGR of 8.2%, Respiratory Monitoring Devices Market is predicted to achieve a value of US$2.79 bn in 2023

As described in a research report released by Transparency Market Research, the fragmented nature of the global respiratory monitoring devices market allows for a very high intensity of rivalry. This market is exceptionally dynamic as it is primarily controlled the rapid rate of technological development in the devices.

The market for respiratory monitoring devices in major economic regions is more or less saturated due to the strong presence of multiple prominent players. As a result, the threat of new entrants is expected to remain moderate to low.

The global market for respiratory monitoring devices is expected to expand at a CAGR of 8.2% in terms of revenue from 2015 to 2023. By the end of 2016, this revenue is expected to reach US$1.60 bn and US$2.79 bn by 2023.

Read Full Report: http://www.transparencymarketresearch.com/respiratory-monitoring-devices.html

Global Respiratory Monitoring Devices Market: Snapshot

Factors at the forefront of driving the demand in the global respiratory monitoring devices market are the rising number of cigarette smokers and a worsening air quality on account of rampant pollution. Further, a burgeoning geriatric population highly susceptible to lung diseases has also pushed up the demand in the market. Countering its growth, however, are the steep prices of newer, sophisticated respiratory monitoring devices, particularly advanced spirometry devices. They are much more expensive than peak flow meters or even pulse oximeters. This has somewhat dampened the demand for improved products leveraging better technologies. Further, dearth of skilled personnel to install advanced respiratory monitoring devices is also creating a gap between demand and supply in the market.

Expanding at a healthy CAGR of 8.2% from 2015 to 2023, the global market for respiratory monitoring devices is predicted to achieve a value of US$2.79 bn in 2023.

Widespread Prevalence of Asthma and COPD makes North America Market Leader

The Centers for Disease Control and Prevention (CDC) pegged chronic lower respiratory disease (COPD) as the third main cause of death in the U.S. in 2014. As per its findings, about 15.7 million people, which is about 6.4% of the nation’s population, were afflicted with COPD in 2014. Numbers were equally alarming for asthma cases. In fact, North America has the maximum cases of COPD and asthma and this has been the single-most important factor driving robust uptake of respiratory monitoring devices in the continent, thereby catapulting it to the leading position in the global market. The market in North America is slated to attain a value of US$266.0 mn by 2023.

Download exclusive Sample of this report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1415

Europe is another dominant market on account of the widespread prevalence of cystic fibrosis. Asia Pacific is proving to be a promising market too due to solid pace of development of healthcare and medical devices industries in the region. Other factors positively impacting its market are the strong economic growth in the densely populated countries of China and India, rising instances of respiratory illnesses, increasing government aid in healthcare development, and soaring popularity of medical tourism. The market in Asia Pacific is expected to register a healthy CAGR of 8.5% from 2015 to 2023.

Hospitals Generate Maximum Revenue due to Better Respiratory Monitoring Devices

Depending upon end users, the global market for respiratory monitoring devices can be segmented into laboratories, hospitals, and home use. Among them, hospitals lead the market with maximum share. Going forward too, it is predicted to retain its dominant share by exhibiting a stellar CAGR of 8.3% from 2015 to 2023. In terms of revenue, hospitals are slated to attain a value of US$1.89 bn by 2023. This is because of the large number of patients opting for treatment in hospitals for different respiratory problems. The trend is most noticeable in developed countries where hospitals have advanced respiratory monitoring devices for diagnosing modern strains of respiratory diseases.

Brochure Download: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1415

In terms of product, the market can be classified into peak flow meter, spirometer, capnograps, and pulse oximeters. The global market for respiratory monitoring devices is dominated by a few players who hold a sizeable chunk of the market share. A host of other smaller players compete with each for the remaining share. Some of the prominent names in the market are CareFusion Corporation, Smiths Medical, and ResMed, Inc. On account of the presence of both large and small players, the global respiratory monitoring devices market is highly competitive. This market is dynamic too as it is characterized by rapid technological development.

Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact us:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.